Nasal Spray Device Sensor Detects Medicine Administration
Summary
USPTO granted patent US12599731B2 to 10XBeta on April 14, 2026 for a nasal spray device with an infrared proximity sensor that detects movement of a graphical image on the nozzle during medicine administration. The sensor can also measure distance to a vial surface within the housing to detect vial insertion. The patent contains 19 claims covering the sensor system and method for tracking controlled medical therapy usage.
What changed
USPTO granted patent US12599731B2 to 10XBeta on April 14, 2026 for a nasal spray device with an infrared proximity sensor that detects movement of a graphical image on the nozzle during medicine administration. The sensor can also measure distance to a vial surface within the housing to detect vial insertion. The 19-claim patent covers sensor technology for controlled medical therapy usage tracking.
Healthcare providers, pharmaceutical companies, and medical device manufacturers may consider monitoring this intellectual property development. The assignee may seek to commercialize the technology through licensing or enforcement against potential infringers. The patent's focus on controlled substance tracking and biometric security features (facial recognition, user authentication) may also be relevant for medication adherence and compliance monitoring applications.
What to do next
- Monitor for updates
Archived snapshot
Apr 16, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
System and method for sensing usage of a controlled medical therapy device
Grant US12599731B2 Kind: B2 Apr 14, 2026
Assignee
10XBeta
Inventors
Marcel Botha, Frederick Zacharias Kruger, Johannes Michiel Bredenkamp
Abstract
A nasal spray device can include housing having a sensor and a nozzle having a housing interface with a graphical image thereon. The sensor can be configured to sense movement of the graphical image when the nozzle moves relative to the housing, for instance during administration of medicine from the nasal spray device. The sensor can include an infrared proximity sensor that senses infrared reflectivity from the graphical image. The infrared proximity sensor can also be used to measure distance to a surface of a vial within the housing to thereby detect insertion of the vial into the housing.
CPC Classifications
A61M 15/08 A61M 15/0086 A61M 15/0083 A61M 15/0081 A61M 11/007 A61M 11/006 A61M 2230/63 A61M 2230/06 A61M 2209/00 A61M 2205/8243 A61M 2205/8206 A61M 2205/7527 A61M 2205/702 A61M 2205/609 A61M 2205/587 A61M 2205/584 A61M 2205/583 A61M 2205/581 A61M 2205/52 A61M 2205/505 A61M 2205/3606 A61M 2205/3592 A61M 2205/3584 A61M 2205/3553 A61M 2205/3386 A61M 2205/3327 A61M 2205/3317 A61M 2205/3306 A61M 2205/276 A61M 2205/18 A61M 2205/14 A61M 2205/103 A61M 2202/0468 A61M 15/0001 A61M 2202/0007 A61M 2210/0618 A61M 2205/3576 A61B 5/4833 A61B 5/1172 A61B 5/02438 B05B 11/1059 B05B 11/0054 B05B 11/0038 B05B 12/02 G06F 21/32 G06F 21/36 G06V 40/1318 G06V 40/10 H04W 12/06 H04L 63/0861 G16H 20/13 A61P 25/24
Filing Date
2021-05-06
Application No.
17313066
Claims
19
Related changes
Get daily alerts for USPTO Patent Grants - Medical Devices (A61M)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Medical Devices (A61M) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.